New Members Named to Diabetes Foundation Board of Trustees

HACKENSACK, NJ – July 23, 2019 – The Diabetes Foundation, New Jersey’s premier not-for-profit organization that empowers individuals living with diabetes, has announced the addition of Elaine Tam and Stanislav Glezer, MD, MBA leading diabetes experts at BD (Becton Dickinson and Company), to its Board of Trustees. As Worldwide Director, Safety & Syringe Franchises, BD Medical – Diabetes Care; and Global Vice President, Medical Affairs, Diabetes Care, respectively, Tam and Glezer bring diabetes insight from one of the world’s largest medical technology companies to the Foundation’s board.

“The addition of these two veterans of the health discovery, diagnostic, and care delivery segments of healthcare brings a new level of insight and understanding to the Foundation’s mission to support, encourage and advocate for those living with diabetes,” said Michael J. Sullivan, Chairman of the Diabetes Foundation's Board of Trustees and a Managing Partner with Sullivan Greenberg Associates. “BD has been a long-standing partner to the Diabetes Foundation, and we appreciate that these two consummate professionals have agreed to bring their experience, expertise, and valuable counsel to our organization.”

Elaine Tam, a resident of Wayne, NJ and part of BD since 2003, currently serves as the Worldwide Director, Safety and Syringe Franchises for BD Medical’s Diabetes Care group. In that capacity, she is the global marketing owner of BD’s safety injection and syringe business. Tam is responsible for driving the three to five year global strategy for the company’s safety injection and insulin syringe franchises, including support of new product development and innovation that addresses the company’s growth strategy and user unmet needs. Prior to that, she served as the Associate Director for the same area and spent a number of years working in the Preanalytical Systems division of BD Diagnostics. Tam received her bachelor’s degree in chemical engineering from Cornell University’s College of Engineering and an MBA in marketing and management from the Columbia Business School.

“In more than a decade and a half at BD, I have been able to see the power that innovation and technology has in the treatment of a range of diagnoses and conditions. In the past three years, I have been directly involved in the development of innovative products that are making a direct impact on the lives of those living with diabetes, and am looking forward to sharing that experience and knowledge with this worthy organization,” said Tam. “I am truly excited to bring my enthusiasm and expertise in this area to the Diabetes Foundation.”

Dr. Stanislav Glezer is BD’s Global Vice President, Medical Affairs, Diabetes Care, a position he assumed in September 2018 following his tenure as Chief Medical Officer at ADOCIA, a French, clinical-stage biotech company, based in Lyon, operating in the diabetes and metabolic disease field. Glezer is a health professional and an industry veteran with hands-on in-depth experience in multiple functions at the strategic and operational level. His personal mission is to improve public health through increasing medical industry efficiency as a partner to the healthcare system. Before his work at BD and ADOCIA, Dr. Glezer worked with a number of leading domestic and international pharmaceutical companies, including Novo Nordisk, Sanofi, Berlex Laboratories, and Teva Pharmaceuticals. He received his Doctor of Medicine Degree, with honors, in General Medicine from the Moscow State University of Medicine and Dentistry, and is a graduate of California Coast University with an MBA degree in international business. He also has completed graduate training in clinical research and health economics at McGill University.

“Much of the Diabetes Foundation’s mission is based on support and advocacy necessary to help those living with diabetes lead healthier lives, and I am looking forward to using my expertise in diabetes and metabolic disorders and my experience in the pharmaceutical and medical device industry to benefit the Foundation,” said Dr. Glezer. “The Diabetes Foundation is providing a valuable support mechanism to the community and I am proud to be part of their efforts across New Jersey.”

For more information on the Diabetes Foundation, visit www.diabetesfoundationinc.org.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit www.bd.com.

About Diabetes Foundation

Founded in 1990, the Diabetes Foundation is a 501(c)(3) dedicated to empowering individuals struggling with prediabetes, Type 1, Type 2, or gestational diabetes. The Foundation is committed to providing access to critical resources and medication necessary for people living with diabetes to remain healthy. The Foundation provides a number of programs serving children, parents, adults, caregivers and their families regardless of income or healthcare coverage. The generous support from patrons and sponsors allows the Diabetes Foundation to continue to offer their services to the community for free. You can learn more about the Foundation at www.diabetesfoundationinc.org.